Open Access

Paradigm shifts in HFrEF management: SGLT2-Inhibitors

Event: ESC Asia with APSC & AFC 2020
Topic: Chronic Heart Failure
Session type: Industry Technology and Innovation session
Sponsored by AstraZeneca
Date: 5 December 2020
Time: 18:00 - 18:30

Congress Session

This content is currently on OPEN ACCESS

Sign in to view the resources

2 presentations in this session

Paradigm shifts in HFrEF management: SGLT2-Inhibitors.

Thumbnail

Q&A - Paradigm shifts in HFrEF management: SGLT2-Inhibitors.

Speaker: Professor C. Chiang (Taipei, TW)
Speaker: Associate Professor J. Tan (Singapore, SG)
Thumbnail

2 speakers from this session

Professor Chern-En Chiang

Taipei Veterans General Hospital, Taipei (Taiwan)
1 presentation
0 follower

Associate Professor Jack Wei Chieh Tan

National Heart Centre Singapore, Singapore (Singapore)
14 presentations
2 followers

This platform is supported by

logo Novo Nordisk